Summary Galanin overexpressing transgenic mice (GAL-tg) were generated on two different promoters. Both lines of GAL-tg displayed high levels of galanin in the hippocampus and reduced sensitivity to seizures, as compared to their respective wildtype littermate controls (WT). Performance deficits on learning and memory tasks, impaired long-term potentiation, reduced hippocampal excitability, lower evoked glutamate release, and reduced numbers of choline acetyltransferase immunoreactive neurons in the horizontal limb of the diagonal band were detected in GAL-tg as compared to WT. Changes in sensitivity to nociceptive stimuli were demonstrated in one line. GAL-tg represent a new model for investigating the biological actions of endogenous galanin, and for testing novel therapeutics based on galanin receptor ligands. ß
INTRODUCTION
Galanin was discovered almost 20 years ago in the laboratory of Viktor Mutt at Karolinska Institute in Stockholm, Sweden (Tatemoto et al., 1983) . The Nterminal sequence of this 29 amino acid neuropeptide (30 amino acids in humans) is highly conserved across species (reviewed in Ho È kfelt et al., 1991; Bartfai et al., 1992; Crawley, 1995) . More recently three galanin receptors have been cloned (reviewed in Iismaa and Shine, 1999; Branchek et al., 2000) . Immunocytochemical localization of galanin in the mammalian brain demonstrated a widespread distribution in the rodent peripheral and central nervous systems, with high concentrations of galanin in hypothalamic nuclei, ventral forebrain, amygdala, hippocampus, brainstem and spinal cord (reviewed in Ho È kfelt et al., 1991 Ho È kfelt et al., , 1998 Merchenthaler et al., 1993; Pe Â rez et al., 2001; Counts et al., 2001) . Coexistence of galanin within the same neuron as a``classical'' neurotransmitter was detected, among others, in the rat noradrenergic locus coeruleus, and to a lesser extent in neurons in the cholinergic basal forebrain, serotonergic dorsal raphe, dopaminergic arcuate nucleus, as well as coexistences of galanin with other neuropeptides including cholecystokinin in spinothalamic neurons and vasopressin in hypothalamic neurons (reviewed in Ho È kfelt et al., 1991; Merchenthaler et al., 1993; . Coexistences differ across species Counts et al., 2001) .
Exogenously administered galanin has several major physiological and behavioral actions in laboratory animals (reviewed in Ho È kfelt et al., 1991 Ho È kfelt et al., , 1998 Crawley, 1995; Wrenn and Crawley, 2001 ). In the spinal cord, galanin has complex actions on pain sensitivity, including attenuation of C-®ber pain transmission and neuropathic pain (reviewed in Xu et al., 2000; Liu et al., 2001 ). In the rat hypothalamus, galanin induces feeding in satiated rats (reviewed in Crawley, 1999) . In the pituitary, galanin induces the release of growth hormone and prolactin (reviewed in Merchenthaler et al., 1993; Wynick et al., 1998) , and inhibits the evoked release of corticotropin and thyrotropin (Hooi et al., 1990) . Given intravenously, galanin reduces norepinephrine levels in plasma, and reduces sympathetic nervous system responses to physiological stressors (degli Uberti et al., 1995; Ceresini et al., 1998) . Given intraventricularly, galanin blocks a conditioned place preference to morphine (Zachariou et al., 1999 ). Galanin appears to mediate behavioral responses to stress responses and anxiety in rodents (Bing et al., 1993; Milot and Trudeau, 1997; Mo È ller et al., 1999; Sweerts et al., 2000) , and to increase depression-like behaviors (Weiss et al., 1998) . Galanin mRNA expression is dramatically elevated after neuronal damage in several systems, suggesting a potential neurotrophic action for galanin (reviewed in Ho È kfelt et al., 1994 Holmes et al., 2000; Shi et al., 2001) .
Galanin-immunoreactive ®bers and terminals appear to hyperinnervate the remaining cholinergic nucleus basalis of Meynert cell bodies in Alzheimer's disease (Chan-Palay, 1988 , 1990 Mufson et al., 1993; Bowser et al., 1997) . Concentrations of galanin are approximately twice as high in basal forebrain samples from end stage Alzheimer's versus age-matched controls, while cholinergic markers are reduced and other local neuropeptides are unchanged (Beal et al., 1990) . Similarly, galanin concentrations are elevated in regions of the cerebral cortex and hippocampus in Alzheimer's versus age-matched controls (Gabriel et al., 1994) . The cause and biological signi®cance of galanin overexpression in Alzheimer's disease is under intense investigation.
In rats, galanin appears to play an inhibitory neuromodulatory role. Galanin inhibits the evoked release of acetylcholine and glutamate in rat hippocampal slices and in vivo microdialysate (Fisone et al., 1987; O È gren et al., 1996; Robinson et al., 1996) . Galanin attenuates the activation of adenylate cyclase and phosphatidyl inositol hydrolysis in rat hippocampus and cortex (reviewed in Karelson and Langel, 1998; Iismaa and Shine, 1999) .
Galanin reduces excitatory activity in CA1 neurons (Dutar et al., 1989) and impairs the development of longterm potentiation in rat hippocampal slices (Sakuri et al., 1996; Mazarati et al., 2000) . Galanin administered into the lateral ventricles and ventral hippocampus impairs performance on learning and memory tasks, including Tmaze delayed alternation, delayed nonmatching to position, Morris water maze, starburst maze, passive avoidance, and spontaneous alternation (reviewed in Crawley, 1995; McDonald et al., 1998a; O È gren et al., 1998; Wrenn and Crawley, 2001) . Deleterious actions of galanin are particularly evident when cholinergic neurotransmission is reduced by treatment with the muscarinic antagonist scopolamine (Robinson et al, 1993) or lesions with a cholinergic immunotoxin (McDonald et al., 1998b) .
A good model system is needed to investigate the biological actions of endogenous galanin. Since galanin is normally expressed at very low levels in several systems including the cholinergic basal forebrain neurons and dorsal root ganglia, it seemed reasonable to attempt to create animals that constitutively express high levels of galanin in such systems. For example, it would be interesting to mimic the overexpression of endogenous galanin observed in the basal forebrain in Alzheimer's disease, or in sensory neurons after peripheral nerve damage, to further our understanding of the speci®c role of galanin in human disease states. In fact, transgenic mice with extra copies of the galanin gene (GAL-tg) have recently been developed, that address this need. Several conditional GAL-tg lines were independently generated. In the line of conditional GAL-tg mice generated by Robert Steiner and coworkers at the University of Washington in Seattle (UW), the galanin gene is linked to a dopamine b-hydroxylase promoter , principally restricting expression to neurons containing norepinephrine and epinephrine. This line was backcrossed for seven generations and bred into a C57BL/6J genetic background. The line of conditional GAL-tg generated by Tomas Ho È kfelt and coworkers at Karolinska Institute (KI) and Tamas Bartfai and coworkers at Stockholm University in Sweden expressed the galanin gene on a platelet derived growth factor B promoter, yielding wider distribution. This line has been backcrossed for ten generations and bred into a C57BL genetic background. A third galanin overexpressing transgenic line was generated by James Hyde and coworkers at the University of Kentucky, wherein the mouse galanin gene was fused to the rat prolactin promoter, thus providing interesting information on the role of galanin in the anterior pituitary (Cai et al., 1999) . The present review focuses on the neuroanatomy of galanin overexpression and its functional consequences in the ®rst two lines of GAL-tg mice, GAL-tg (UW) and GAL-tg (KI), as published at the time of this review (Mazarati et al., 2000; Holmberg et al., 2000; Blakeman et al., 2001; Kehr et al., 2001; Steiner et al., 2001; Kokaia et al., 2001; Holmes et al., 2002) .
MUTANT MOUSE PHENOTYPES Overexpression levels
In situ hybridization and quantitation of galanin mRNA in the GAL-tg (UW) revealed ®ve times more galanin mRNA in the locus coeruleus of GAL-tg as compared to WT . Ectopic expression of galanin mRNA was detected in the piriform and entorhinal cortex and subiculum, as compared to undetectable levels of galanin mRNA in WT controls . In this regard, galanin peptide was not detected in these regions in the normal C57BL/6 mouse brain (Pe Â rez et al., 2001) . Radioimmunoassay for total galanin peptide content revealed approximately twice as much galanin in the forebrain . In a separately bred derivation of GAL-tg (UW), radioimmunoassay revealed four times as much galanin in the hippocampus, and nine times as much galanin in the cerebral cortex in GAL-tg as compared to WT (unpublished data, Gary Wenk and Lisa Marriott, University of Arizona; JNC and co-workers). Immunocytochemical demonstration of galanin overexpression in the hippocampus of GAL-tg (UW) as compared to WT is illustrated in Figure 1 . GAL-tg (KI) displayed high levels of galanin mRNA and galanin-like immunoreactivity in, among others, the frontal cortex, parietal cortex, piriform cortex, hippocampal dentate granule and CA1±CA3 cell layers ( Figure 2A , B), motoneurons ( Figure 3A ), sympathetic and dorsal root ganglia, and skin, especially sweat glands ( Figure 3C ) as compared to WT controls ( Figure 3B , D) (Holmberg et al., 2000 (Holmberg et al., , 2002 Blakeman et al., 2001; Kokaia et al., 2001) . Radioimmunoassay revealed 4±9 fold increases in galanin peptide levels in cortical/hippocampal regions, and HPLC showed that the immunoreactive component eluted in the position of synthetic galanin (Kokaia et al., 2001) . A particularly high expression was seen in the granule cellmossy ®ber system of the dentate gyrus (Kokaia et al., 2001) .
Neurotransmitter release
Hippocampal slices from GAL-tg and WT (UW) were analyzed for glutamate release (Mazarati et al., 2000) . Basal glutamate concentrations were similar in GAL-tg and WT. During 60 mM potassium-induced depolarization, WT displayed the expected increase in glutamate accumulation in the bath, while GAL-tg did not show a signi®cant increase in glutamate accumulation. This result suggests that overexpressed galanin in GAL-tg is released during neuronal stimulation and inhibits the release of glutamate in the mouse hippocampus (Mazarati et al., 2000) . Kokaia et al. (2001) indirectly arrived at a similar conclusion with regard to the granule cell-mossy ®ber system. Thus, they employed electrophysiological experiments analyzing synaptic transmission at mossy ®ber-CA3 cell synapse with so called frequency facilitation, which is a form of short term plasticity where postsynaptic responses are augmented at high frequency stimulation due to increased probability of glutamate release from mossy ®bers (Cremer et al., 1998) . Such frequency facilitation was low in GAL-tg (KI) mice as compared to WT controls, and the putative galanin antagonist M35 increased this facilitation in GAL-tg but not in WT, suggesting that overexpressed galanin inhibited glutamate release in this situation (Kokaia et al., 2001 ). Norepinephrine and serotonin release from 10 month old GAL-tg and WT (KI) was analyzed with in vivo microdialysis in the ventral hippocampus of awake mice (Kehr et al., 2001) . Basal levels were similar between genotypes. Intraventricular administration of galanin, 1 nmole, decreased norepinephrine levels to a greater extent in WT than GAL-tg. . Also in the remaining grey matter there is no dramatic difference between the two genotypes. However, note strongly labeled motoneurons (arrowheads) and preganglionic neuron (double arrowhead) in the sympathetic lateral column in the transgene mouse (A), which cannot be seen in the WT (B). Note also strong labeling of dorsal root (large arrowhead in A) and strong galanin-LI close to the midline (curved arrow in A) in the transgene mouse. This cannot be seen in the WT (B). (C, D) Numerous fibers in the sweat gland contain galanin-LI in the GAL-tg (KI) mouse (C), whereas only single fibers can be seen in the WT mouse (big arrowhead in D). The galanin fibers in the sweat gland in the transgene are cholinergic sympathetic fibers. There are also many more galanin-positive fibers close to the epithelium in the transgene (small arrowheads in C) as compared to the WT mouse (small arrowhead in D). These fibers are presumably sensory fibers. This ®nding is interpreted as a change in signal transduction mechanisms in GAL-tg (Kehr et al., 2001) . Forced swim increased norepinephrine and serotonin levels to a greater extent in the GAL-tg than in the WT. These ®nd-ings are interpreted as greater sensitivity of GAL-tg to stress, suggesting an anxiogenic action of galanin in these mutant mice (Kehr et al., 2001) . Further interpretation of these data will depend on the results of ongoing studies of GAL-tg mice in assays for downregulation and upregulation of galanin receptors, other neurotransmitters and receptors, and alterations in signal transduction mechanisms.
Learning and memory
GAL-tg (UW) displayed performance de®cits on three different types of learning and memory tasks, as summarized in Table 2 . GAL-tg and WT were tested at 26 months of age on social transmission of food preference, an olfactory memory task. Mice must remember the odor of a¯avored food eaten by a cagemate, to show a preference to eat more of that familiar¯avored food than a novel¯avored food the next day. WT showed the expected preference for the familiar¯avored food, 24 hours after the familiarization interaction. GAL-tg failed to show the expected preference ). GAL-tg and WT were tested at ages 8, 16, and 24 months in the Morris water task. Selective quadrant search was displayed by the WT on the probe trial, as expected. WT mice spent more time in the trained quadrant than in the other three quadrants of the pool, and crossed the former location of the hidden platform more frequently than the analogous locations in the other three quadrants, at all three ages. GAL-tg failed to show a selective quadrant search at all three ages . Adult GAL-tg and WT were tested on both standard and trace fear conditioning. Both GAL-tg and WT displayed the expected freezing to the environmental context and to the auditory cue that had previously been paired with footshock in the standard delay version of fear conditioning. However, in the trace version of fear conditioning, when the footshock is separated from the auditory cue by several seconds, the GAL-tg displayed signi®cantly less freezing than the WT (Kinney et al., in press ). GAL-tg (UW) were normal on measures of general health, neurological re¯exes, sensory abilities including olfaction, vision, hearing, and nociception, and motor abilities including locomotion and swimming to the visible platform Holmes et al., 2002) . Therefore, the physical abilities needed to conduct the procedures of the learning and memory tasks were intact. These data support the interpretation that overexpressed galanin impairs cognitive processes across a range of tasks, particularly on the more dif®cult components of learning and memory tasks. Additional ®ndings that GAL-tg (UW)
show impaired long-term potentiation in hippocampal slices (Mazarati et al., 2000) , accompanied by reductions in evoked release of glutamate (Mazarati et al., 2000) , suggest that a glutamaterigic mechanism in the hippocampus may underlie the cognitive de®cits resulting from galanin overexpression Wrenn and Crawley, 2001) .
Neuronal survival
To test whether the cognitive de®cits in GAL-tg mice might be associated with perturbations in basal forebrain cholinergic systems, we performed counts of immunoreactive choline acetyltransferase (ChAT)-containing cells in the horizontal limb of the diagonal band (HDB). As shown in Figure 4C GAL-tg (UW) displayed a reduction in choline acetyltransferase immunoreactive cells in the basal forebrain horizontal limb of the diagonal band, as compared to WT . No genotype differences were detected in choline acetyltransferase immunoreactive neurons in the medial septum, vertical limb of the diagonal band, or nucleus basalis of Meynert. This ®nding is discussed in light of one report suggesting that in the horizontal limb of the diagonal band, only the GAL-R1 galanin receptor subtype is expressed, whereas both GAL-R1 and GAL-R2 subtypes are expressed in the vertical limb of the diagonal band (O'Donnell et al., 1999) . To determine whether the apparent loss of identi®able ChAT-containing neurons re¯ected their death (a frank loss) or simply a reduction in ChAT content to below the limits of detectability by immunocytochemistry, we performed in situ hybridization for ChAT mRNA and measured the number of cells expressing ChAT mRNA, and the average ChAT mRNA content per cell, in the HDB. Figure 4B demonstrates a modest reduction in ChAT mRNA per cell in GAL-tg mice as compared to WT mice. However, there was no detectable difference in ChAT mRNA-containing cell counts between the GAL-tg and WT ( Figure 4A ). These results suggest that galanin overexpression reduces the cholinergic phenotype in the basal forebrain, which could contribute to cognitive de®cits in GAL-tg mice. However, actual survival of cholinergic neurons in the HDB appears to be unaffected by the overexpression of galanin in the GAL-tg (UW).
Anxiety
GAL-tg and WT (UW) displayed similar scores on three tests for anxiety-related behaviors, the elevated plus maze, light $ dark exploration, and open ®eld center time . Both WT and GAL-tg showed anxiolytic responses to chlordiazepoxide on the light $ dark exploration test. However, anxiogenic behaviors were induced in WT by yohimbine, an a2 adrenergic receptor antagonist, whereas GAL-tg showed no response to yohimbine on light $ dark exploration. These results support the notion that galanin produces an anxiolytic action under conditions of high noradrenergic activation Table 2 GAL-tg (UW) displayed deficits on the more difficult components of three learning and memory tasks. Performance was significantly impaired on the Morris probe trial, olfactory memory of a socially transmitted food preference, and trace fear conditioning to an auditory cue. These three tasks represent conceptually different types of memory with divergent sensory and motor demands. Normal scores were seen in GAL-tg (UW) on measures of general health, sensory abilities, and motor functions, and on the less challenging and control components of the cognitive tasks, indicating that GAL-tg mice are physically able to perform all of the procedures required to conduct these tasks. Therefore, the specific learning and memory deficits were not artifacts of physical disabilities. Rather, GAL-tg (UW) demonstrate a highly selective impairment in difficult cognitive tasks acid induced a larger number of stage 5 seizures in WT than in GAL-tg (UW), along with signi®cantly greater numbers of injured neurons in WT than GAL-tg (Mazarati et al., 2000) . Pentylenetetrazole induced doserelated seizures that were approximately four-fold more severe in WT than in GAL-tg (UW) (Mazarati et al., 2000) . Hippocampal kindling induced seizures in WT with a faster time course than in GAL-tg (KI), and this difference was still present when the animals were re-kindled (Kokaia et al., 2001) . Similar results from these three seizure models provides strong corroborative evidence that excess galanin protects against evoked seizures. The mechanism underlying the ability of galanin to reduce the number, severity, and time course of induced seizures is postulated to be the ability of galanin to reduce glutamate release under high levels of neuronal activation (Ben-Ari and Lazdunski, 1989; Mazarati et al., 2000; Kokaia et al., 2001 ).
Analgesia
GAL-tg (KI) displayed signi®cantly higher latencies on two measures of pain perception, tail¯ick and paw withdrawal from radiant heat stimulation, as compared to WT controls (Hygge Blakeman et al., 2001 Xu et al., 2000) . In a second series of experiments with GAL-tg (KI), an enhanced pain behavior was observed in the formalin test (Holmberg et al., 2002) , underscoring the complexity of the role of galanin in pain control. However, mustard-induced plasma extravasation was attenuated in the transgenic as compared to the WT mouse, supporting previous data on the inhibitory effect of galanin in the peripheral terminals of primary afferents (Xu et al., 1991) . GAL-tg (UW) were not signi®cantly different than WT littermate controls on the hot plate or tail¯ick tests Holmes et al., 2002) . However, recent results by Hygge Blakeman et al. (2001) showed a small, but signi®cant, increase in heat pain threshold in the GALtg (UW) mice. The explanation for the discrepancy in ®nd-ings between the KI and the UW GAL-tg mice and between different laboratories on measures of analgesia remains to be determined, but may be due to differences in the level of golanin over expression in different lines of mice (Holmberg et al., 2002) , different methods of nociceptive testing, and the fact that the effect observed by Hygge Blakeman et al. in both GAL-tg (KI) and GAL-tg (UW) is fairly modest. Importantly, however Hygge Blakemen et al. (2002) have recently shown that the development of neuropathic pain-like behaviors was signi®cantly reduced in GAL-tg (UW) compared to WT. This would support the hypothesis that galanin is antinociceptive after nerve injury (Wiesenfeld-Hallin et al., 1992) .
ADDITIONAL PARAMETERS
Measures of general health, home cage behaviors, neurological re¯exes, sensory abilities, and motor functions, were normal in GAL-tg (UW) , Supplementary Material on-line; Holmes et al., 2002) . Breeding was normal on measures of pregnancies, litter size, and pup survival. No genotype differences were detected on gross measures of home cage nesting and group sleeping patterns, appearance of fur and whiskers, righting re¯ex, eye blink re¯ex, ear twitch re¯ex, whisker twitch re¯ex, body posture or gait. Exploratory locomotion was not signi®cantly different than WT controls on the Digiscan open ®eld measures of horizontal activity and vertical activity. Latency to fall from the rotarod was not signi®cantly different between genotypes. Acoustic startle and prepulse inhibition were not signi®cantly different between genotypes. Body weights were not signi®cantly different between GAL-tg and WT controls as measured up to 42 weeks of age. Body temperatures were similar in the two genotypes. The GAL-tg (KI) has so far not been investigated to a similar extent with regards to all of these parameters, but general health appears normal with no differences in body weight between transgenics and WT.
CONCLUSIONS
The studies conducted to date on two lines of galanin overexpressing transgenic mice indicate that GAL-tg mutant mice are healthy and normal on a variety of physiological and behavioral measures. Speci®c phenotypic differences in GAL-tg as compared to WT controls were discovered in both lines. GAL-tg displayed lower levels of induced seizures, reduced hippocampal glutamate release, and reduced anxiety-related responses to an anxiogenic drug (Mazarati et al., 2000; Kokaia et al., 2001; Holmes et al., 2002) , consistent with previously reported actions of exogenously administered galanin on seizures (Mazarati et al., 1998) and anxiety (Bing et al., 1993) . Replication of the seizure resistance in the two independent lines of GAL-tg con®rms the reliability of this phenotype, and suggests a potential therapeutic indication for galanin agonists and/or gene transfer in the treatment of epilepsy (Kokaia et al., 2001; Mazarati et al., 2001) . Selective de®cits in GAL-tg on learning and memory tasks are consistent with the pharmacological literature showing inhibitory actions of exogenously administered galanin in rats (McDonald et al., 1998a; Wrenn and Crawley, 2001) . Galanin overexpressing mice with cognitive de®cits represent a new model system to test hypotheses about the role of overexpressed galanin in the memory loss associated with Alzheimer's disease. Lines of galanin overexpressing mice may prove useful for evaluating galanin receptor antagonists for their potential therapeutic ef®cacy in treating the cognitive symptoms of Alzheimer's disease. Another useful model in this regard is the V717F b-amyloid precursor protein transgenic mouse, which displays a high level of galanin overexpression in the mossy cells, granule cells, and lamina moleculare-lacunosum layers of the hippocampus .
Whether Alzheimer's pathological lesions play a role in the induction of the overexpression of galanin is an intriguing question. Human neuropathological studies have shown that neuritic plaques contain galanin (Kowall and Beal, 1989) , while neuro®brillary tangles are not immunopositive for galanin (unpublished observations, EJM and coworkers). However, studies using the transgenic mice carrying the mutation V->F in position 717 of the human amyloid precursor protein gene provide support for the proposition that amyloid plaques may trigger increased galanin expression. In this study, 26 month old transgenic mice that exhibited increased amyloid-containing plaques displayed a striking upregulation of galaninergic ®bers in the hippocampus and entorhinal cortex areas that are ®rst affected in Alzheimer's disease (Braak and Braak, 1991) . In addition, many of the amyloid plaques contained dystropic, galanin-containing neurites, where occasionally even peptide-positive cell bodies were incorporated in these mutant mice . Since the hippocampal complex contains extensive amyloid deposition (Brady and Mufson, 1991) , it is possible that amyloid may activate galanin overexpression either by a neurotoxic or a neurotrophic effect. In fact, it has been observed that nerve injury in several neural systems causes an up-regulation of galanin synthesis (reviewed in Ho È kfelt et al., 1994 Palkovits, 1995) . It is, therefore, possible that increases in galaninergic systems seen in both the PDAPP mice and in humans with Alzheimer's disease represent a response to neuronal damage induced by increased Ab levels. In fact, the increase in galanin in these disease states may represent an attempt aimed at repair. In this regard, we have suggested that the increase seen in galaninergic systems in late stage AD may be an aborted or end stage plasticity response (Counts et al., 2001) . To what extent galanin overexpression in Alzheimer's disease re¯ects a bene®cial action on the neurodegenerative process, and to what extent galanin overexpression causes a worsening of cognitive symptoms, remains to be determined.
It is interesting to compare the cognitive phenotype of the GAL-tg (UW) to the cognitive phenotype of a galanin knockout mouse, described in this volume (Wynick review) and previously (O'Meara et al., 2000) . Galanin null mutants were reported to show age-dependent deficits on the Morris water task, signi®cant for genotype at age 10 months but not at age 4 months. This line of galanin knockouts displayed impairments in hippocampal longterm potentiation, and with regard to evoked acetylcholine release in the hippocampus. Thus, the hippocampal and cognitive phenotype in these galanin de®cient mice appears to be in the same direction as in the galanin overexpressing mice (GAL-tg UW). However, the cognitive deficits were not age-dependent in the GAL-tg, but rather were detectable as early as age 8 months .
Galanin null mutants displayed a loss of choline acetyltransferase immunoreactive (ChAT) cells in the basal forebrain medial septum and vertical limb of the diagonal band (O'Meara et al., 2000) . These sets of ChAT-immunoreactive basal forebrain nuclei were normal in the GAL-tg (UW), whereas the GAL-tg (UW) showed lower numbers of ChAT-immunoreactive neurons in the horizontal limb of the diagonal band . If replicated, results from the galanin null mutants and GAL-tg suggest that there is an optimal concentration of galanin necessary for full cognitive abilities and survival of basal forebrain cholinergic neurons. Either too much galanin or too little galanin appears to be detrimental to cellular components of the cholinergic basal forebrain as well as hippocampal function.
It is interesting to note that the decrease in number of ChAT-immunoreactive neurons in the galanin null mutants is not due to the loss of these neurons but instead is the result of a phenotypic downregulation of speci®c cholinergic markers. Interestingly, the deletion of the galanin gene results in a reduction in the number of ChAT and trkA immunoreactive neurons in the basal forebrain (O'Meara et al., 2000) , but not basal forebrain neurons containing the low af®nity p75 neurotrophin receptor (NTR) (Ma et al., 1999) . Since virtually all cholinergic basal forebrain neurons contain ChAT as well as the high trkA and low af®nity p75 (NTR) receptors (Sobreviela et al., 1994; Gibbs and Pfaff, 1994) , these observations suggest that galanin plays a role in the phenotypic regulation of select proteins during the development of cholinergic basal forebrain neurons. Relevant to the hypothesis that galanin may regulate in multiple fashion the expression of speci®c proteins in neurons, is a new ®nding that galanin and its three receptors are among a small number of genes uniquely expressed in pluripotent embryonic stem cells as compared to partially differentiated adult stem cells (Anisimov et al., 2002) . The reduction in pain sensitivity in GAL-tg (KI) is consistent with the analgesic actions of exogenously administered galanin in the spinal cord (Wiesenfeld-Hallin et al., 1992; Xu et al., 2000; Wiesenfeld-Hallin and Xu, 2001 ). Using a GAL-R2 subtype selective agonist, AR-M1896, Liu and coworkers (2001) provided evidence that galanin has nociceptive actions in the spinal cord through a GAL-R2 receptor subtype, in contrast to antiallodynic actions on neuropathic pain at higher doses through a GAL-R1 receptor subtype. This hypothesis can be tested in the future with the use of GAL-R1 de®cient mice. GAL-tg mice provide a useful model system to further test galanin receptor subtype-selective compounds for analgesic actions in models of clinical neuropathies.
The GAL-tg model awaits additional key experiments. Correlations between level of overexpression and degree of phenotype may be revealing. Rescue of the several phenotypes by treatment with a galanin receptor antagonist, or a genetic knock-in, or breeding of GAL-tg with galanin null mutants, is a critical test of the assumption that the aberrant phenotypes are caused directly by extra copies of the galanin gene. DNA microarrays of brain regions from GAL-tg and WT controls may discover important genes that are activated or suppressed when galanin is overexpressed throughout development. Downstream genes may represent mechanisms through which galanin overexpression results in phenotypic changes. Compensatory genes may be responsible for masking expected phenotypes in domains such as feeding. Inducible mutations, to increase galanin overexpression during a restricted time period, would allow us to ask more speci®c questions about the consequences of excess endogenous galanin, e.g. are memory de®cits greater when galanin is overexpressed only at older ages. Comparison of phenotypes on the two promoters, and generation of GAL-tg using other relevant promoters, will help to con®rm the speci®city of each phenotype to galanin overexpression. Galanin overexpressing transgenic mice displaying prominent phenotypes represent a useful research tool to evaluate new nonpeptide, bioavailable, subtype-selective galanin receptor antagonists, to further our understanding of the role of each galanin receptor subtype in the behavioral, physiological, and neurochemical actions of this interesting neuropeptide.
